Association of serum pentosidine with arterial stiffness in hemodialysis patients

Artificial Organs

Volumn 34, Issue 3, 2010, Pages 193-199

  Zhou, YiLun ^a   Yu, ZeXing ^a   Jia, HuiMin ^a   Sun, Fang ^a   Ma, LiJie ^a   Guo, RuiJun ^a   Peng, Liren ^a   Cui, TaiGen ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Advanced glycation end products; Arteriosclerosis; Hemodialysis

Indexed keywords

BLOOD PRESSURE; BODY FLUIDS; CALCIUM; CARDIOLOGY; DISEASES; HEMODIALYZERS; MULTIVARIANT ANALYSIS; PHOSPHORUS; REGRESSION ANALYSIS; STIFFNESS;

ADVANCED GLYCATION END PRODUCTS; ARTERIAL STIFFNESS; ARTERIOSCLEROSE; C-REACTIVE PROTEINS; DISTENSIBILITY; HAEMODIALYSIS; HEMODIALYSIS PATIENT; HIGH SENSITIVITY; OXIDIZED LOW-DENSITY LIPOPROTEINS; PENTOSIDINE;

DIALYSIS;

ALBUMIN; C REACTIVE PROTEIN; CALCIUM; LIPID; LOW DENSITY LIPOPROTEIN; PARATHYROID HORMONE; PENTOSIDINE; PHOSPHORUS;

ADULT; AGE; ALBUMIN BLOOD LEVEL; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTICLE; BIOACCUMULATION; BLOOD CHEMISTRY; BLOOD PRESSURE; CALCIUM BLOOD LEVEL; CARDIOVASCULAR DISEASE; CAROTID ARTERY; COMMON CAROTID ARTERY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INTRAVASCULAR ULTRASOUND; KIDNEY FAILURE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 77949702399     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2009.00801.x     Document Type: Article

References (25)

1. Rostand SG, Gretes JC, Kirk KA, Rutsky EA, Andreoli TE. Ischemic heart disease in patients with uremia undergoing maintenance hemodialysis. Kidney Int 1979 16 : 600 611.
2. Guerin AP, Pannier B, Marchais SJ, London GM. Cardiovascular disease in the dialysis population: prognostic significance of arterial disorders. Curr Opin Nephrol Hypertens 2006 15 : 105 110.
3. London GM, Drueke TB. Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int 1997 51 : 1678 1695.
4. Yoshida N, Okumura K, Aso Y. High serum pentosidine concentrations are associated with increased arterial stiffness and thickness in patients with type 2 diabetes. Metabolism 2005 54 : 345 350.
5. Schram MT, Schalkwijk CG, Bootsma AH, Fuller JH, Chaturvedi N, Stehouwer CD. Advanced glycation end products are associated with pulse pressure in type 1 diabetes: the EURODIAB prospective complications study. Hypertension 2005 46 : 232 237.
6. Weiss MF, Erhard P, Kader-Attia FA, et al. Mechanisms for the formation of glycoxidation products in end-stage renal disease. Kidney Int 2000 57 : 2571 2585.
7. Busch M, Franke S, Muller A, et al. Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein. Kidney Int 2004 66 : 338 347.
8. Wagner Z, Molnar M, Molnar GA, et al. Serum carboxymethyllysine predicts mortality in hemodialysis patients. Am J Kidney Dis 2006 47 : 294 300.
9. Perloff D, Grim C, Flack J, et al. Human blood pressure determination by sphygmomanometry. Circulation 1993 88 : 2460 2470.
10. Kool MJ, van Merode T, Reneman RS, Hoeks AP, Struyker Boudier HA, Van Bortel LM. Evaluation of reproducibility of a vessel wall movement detector system for assessment of large artery properties. Cardiovasc Res 1994 28 : 610 614.
11. Sanaka T, Funaki T, Tanaka T, et al. Plasma pentosidine levels measured by a newly developed method using ELISA in patients with chronic renal failure. Nephron 2002 91 : 64 73.
12. Sell DR, Nagaraj RH, Grandhee SK, et al. Pentosidine: a molecular marker for the cumulative damage to proteins in diabetes, aging, and uremia. Diabetes Metab Rev 1991 7 : 239 251.
13. Izuhara Y, Miyata T, Saito K, et al. Ultrapure dialysate decreases plasma pentosidine, a marker of carbonyl stress. Am J Kidney Dis 2004 43 : 1024 1029.
14. Suliman ME, Heimburger O, Barany P, et al. Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy. J Am Soc Nephrol 2003 14 : 1614 1622.
15. Nazratun N, Mahmood AA, Kuppusamy UR, Ahmad TS, Tan SY. Diabetes mellitus exacerbates advanced glycation end product accumulation in the veins of end-stage renal failure patients. Vasc Med 2006 11 : 245 250.
16. Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME, London GM. Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension 1998 32 : 570 574.
17. Lee AT, Cerami A. Role of glycation in aging. Ann N Y Acad Sci 1992 663 : 63 70.
18. Kass DA, Shapiro EP, Kawaguchi M, et al. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation 2001 104 : 1464 1470.
19. Sakata N, Noma A, Yamamoto Y, et al. Modification of elastin by pentosidine is associated with the calcification of aortic media in patients with end-stage renal disease. Nephrol Dial Transplant 2003 18 : 1601 1609.
20. Kitauchi T, Yoshida K, Yoneda T, et al. Association between pentosidine and arteriosclerosis in patients receiving hemodialysis. Clin Exp Nephrol 2004 8 : 48 53.
21. Taki K, Takayama F, Tsuruta Y, et al. Oxidative stress, advanced glycation end product, and coronary artery calcification in hemodialysis patients. Kidney Int 2006 70 : 218 224.
22. Yoshida S, Yamada K, Hamaguchi K, et al. Immunohistochemical study of human advanced glycation end-products (AGE) and growth factors in cardiac tissues of patients on maintenance dialysis and with kidney transplantation. Clin Nephrol 1998 49 : 273 280.
23. Suliman ME, Stenvinkel P, Jogestrand T, et al. Plasma pentosidine and total homocysteine levels in relation to change in common carotid intima-media area in the first year of dialysis therapy. Clin Nephrol 2006 66 : 418 425.
24. Zoccali C, Mallamaci F, Asahia K, et al. Pentosidine, carotid atherosclerosis and alterations in left ventricular geometry in hemodialysis patients. J Nephrol 2001 14 : 293 298.
25. Reneman RS, van Merode T, Brands PJ, Hoeks AP. Inhomogeneities in arterial wall properties under normal and pathological conditions. J Hypertens Suppl 1992 10 : S35 9.